Order Article Reprints

Mildenberger V, Alpízar-Pedraza D, Martell-Huguet EM, Krämer M, Bolotnikov G, Otero-Gonzalez AJ, Weil T, Rodriguez-Alfonso A, Preising N, Ständker L, et al. The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity. Pharmaceuticals. 2024; 17(1):83. https://doi.org/10.3390/ph17010083

Mildenberger, Vanessa, Daniel Alpízar-Pedraza, Ernesto M. Martell-Huguet, Markus Krämer, Grigory Bolotnikov, Anselmo J. Otero-Gonzalez, Tanja Weil, Armando Rodriguez-Alfonso, Nico Preising, Ludger Ständker, and et al. 2024. "The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity" Pharmaceuticals 17, no. 1: 83. https://doi.org/10.3390/ph17010083

Mildenberger, V., Alpízar-Pedraza, D., Martell-Huguet, E. M., Krämer, M., Bolotnikov, G., Otero-Gonzalez, A. J., Weil, T., Rodriguez-Alfonso, A., Preising, N., Ständker, L., Vogel, V., Spellerberg, B., Kissmann, A.-K., & Rosenau, F. (2024). The Designed Pore-Forming Antimicrobial Peptide C14R Combines Excellent Activity against the Major Opportunistic Human Pathogen Pseudomonas aeruginosa with Low Cytotoxicity. Pharmaceuticals, 17(1), 83. https://doi.org/10.3390/ph17010083